Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Children and Adolescents With Life Threatening Diseases
NCT00180830Phase 2Terminated
- Sponsor
- Gustave Roussy
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of imatinib in cancer, sponsored by Gustave Roussy. Started Dec 2003; status: terminated.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00180830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180830.